P1.14-08 Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants
Autor: | Robichaux, J., Le, X., Elamin, Y., Nilsson, M., Hu, L., He, J., Zhang, F., Poteete, A., Sun, H., Rinsurongkawong, W., Cross, J., Heymach, J. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S555-S555 |
Databáze: | ScienceDirect |
Externí odkaz: |